Nanalysis Scientific Corp. to Present at the 10th Annual Gateway Conference on September 9, 2021

Nanalysis Scientific Corp. (TSXV:NSCI)(OTCQX:NSCIF) has been invited to present at the 10th Annual Gateway Conference, which is being held virtually on September 8-9, 2021

Nanalysis CEO, Mr. Sean Krakiwsky, is scheduled to present on Thursday, September ­­9 at 11 a.m. Mountain time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay HERE.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email conference@gatewayir.com.

Nanalysis will also be participating in the upcoming LD Micro event on October 12, 2021, at 9.30 a.m. MT. This is an in-person event and can also be attended virtually by following the link HERE. Investors interested in attending in person can sign up HERE.

About the Gateway Conference

For the past nine years, the Gateway Conference has engaged the management teams of nearly 800 public and private growth companies, and thousands of institutional investors, sell-side analysts and sponsoring investment bankers. Past attendees have valued the event for its direct access to high-quality companies and investors. Follow the Gateway Conference on Twitter and join the conversation using the #GatewayIRConference hashtag. For more information, visit gateway-grp.com/conference/.

About the LD Micro Conference

LD Micro is famous for the gatherings it puts together, and while this will be smaller, the level of excitement, energy, and knowledge to be gained will far surpass anything we've ever done.

About Nanalysis Scientific Corp. (TSXV:NSCI)(OTCQX:NSCIF)(FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol “NSCI,” Over the Counter (OTC) in the United States under the ticker symbol “NSCIF," and on the Frankfurt Exchange (FRA) under the symbol “1N1.”

Nanalysis is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D).

Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its cutting edge 60 and 100 MHz spectrometers require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including, but not limited to, oil and gas, chemical mining, pharmaceutical, and biotechnology.

Through its European subsidiary RS2D, the Company offers electronic boards and software used to drive MRI equipment in pre-clinical configurations and are being incorporated into next-gen MRI systems.

To sign up for updates relating to Nanalysis, please complete the online form found HERE.

SOURCE: Nanalysis Scientific Corp.



View source version on accesswire.com:
https://www.accesswire.com/663023/Nanalysis-Scientific-Corp-to-Present-at-the-10th-Annual-Gateway-Conference-on-September-9-2021

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Linius Technologies Limited

Linius Technologies Limited (ASX: LNU) – Trading Halt

Description

The securities of Linius Technologies Limited (‘LNU’) will be placed in trading halt at the request of LNU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 8 July 2024 or when the announcement is released to the market.

Keep reading...Show less
XReality Group

Operator XR – Sales Update June 24

xReality Group Limited (“XRG” or the “Company”) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less
XReality Group

Operator XR –Awarded $800,000 Government Contract

xReality Group Limited (“XRG” or the “Company”) is pleased to announce the sale of multiple systems of its Operator XR Virtual Reality Training System to a new Australian State Government customer.
Keep reading...Show less
XReality Group (ASX:XRG)

XReality Group


Keep reading...Show less
Linius Technologies Limited

Linius Now Live with First Deployment in American Football

Linius Technologies Limited (ASX:LNU) (Linius or Company) – the only cloud-based solution that unlocks the value of video archives with immersive, deeply personalized viewer experiences via its Linius Media Solutions portfolio – is pleased to announce that the deployment of its sports solution, Whizzard, is now live with its customer Lone Star Conference.

Keep reading...Show less
Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that a detailed biomarker analysis of the recently reported pre-clinical melanoma study conducted at Dalhousie University (the "Study") indicates that, beyond shrinking tumors on its own, Sona's Targeted Hyperthermia Therapy ("THT") also stimulates the innate immune system to target and eliminate untreated (contralateral) tumors when combined with a standard immunotherapeutic drug, IL-2. (See figure #1, below.) On the basis of efficacy data achieved in two different murine cancer models (triple negative breast cancer and malignant melanoma), the Company is now proceeding with safety and biocompatibility testing that will be required by regulating agencies to enter into human studies.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×